Updated:
Newton Biocapital Partners
Newton Biocapital is a life sciences investment firm leveraging innovation in Europe and Japan. Its mission is to mature innovation and support the growth of...
Overview
Newton Biocapital is a life sciences investment firm leveraging innovation in Europe and Japan. Its mission is to mature innovation and support the growth of portfolio companies to create value for patients, society, local ecosystems, and investors. The firm invests in early-stage companies in both regions, focusing on solutions for chronic health conditions, and participates proactively as board members.
General information
Firm type
Private Equity
Year founded
2017
Location
Region
Europe
Country
Belgium
City
Brussels
Corporate office
Avenue de Tervueren 273, 1150 Brussels, Belgium
Additional offices
Tokyo, Japan
Principals
Alain Parthoens
Chief Executive Officer
Sadashi Suzuki
Japan Representative
Guy Heynen
Chief Medical and Regulatory Officer
Michihiko Wada
Chief Regulatory and Development Officer
Danny Gonnissen
Chief Operating Officer
Pierre Detrixhe
Venture Director
Tomoko Asaoka
Scientific Director
Dario Padovani
Chief Financial Officer
Daisuke Morishita
Venture Partner
Goro Takeda
Founder
Sector focus
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: